EF Hutton Acquisition Co. I restated their buy rating on shares of HCW Biologics (NASDAQ:HCWB – Get Rating) in a research note released on Thursday morning, Benzinga reports. The brokerage currently has a $9.00 price objective on the stock. HCW Biologics Stock Down 4.1 % Shares of NASDAQ:HCWB opened at $1.39 on Thursday. The company […]
HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) CFO Rebecca Byam acquired 7,596 shares of the stock in a transaction dated Monday, June 13th. The shares were bought at an average cost of $2.08 per share, with a total value of $15,799.68. Following the completion of the transaction, the chief financial officer now owns 96,596 shares […]
HCW Biologics Inc. (NASDAQ:HCWB – Get Rating) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 14,900 shares, a drop of 54.6% from the May 15th total of 32,800 shares. Based on an average daily volume of 28,400 shares, the days-to-cover ratio is […]